Brief: 10X Genomics Q2 Revenue USD 153.1 Million Vs. IBES Estimate USD 150.1 Million
08/08/2024 21:04
Aug 08 (Reuters) - 10X Genomics Q2 gross margin 68%. * Q2 operating income USD -41.7 million vs. IBES estimate USD -58.8 million * Q2 net income USD -37.9 million vs. IBES estimate USD -58.3 million * outlook FY revenue USD 640-660 million
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences